OncBioMune Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
512.50
13.00
6.80
-
1.40
0.20
Total Accounts Receivable
50.60
-
-
11.20
-
-
Other Current Assets
22.60
4.90
0.10
30.10
12.70
215.70
Total Current Assets
585.70
17.90
6.90
41.30
14.10
215.90
Net Property, Plant & Equipment
-
-
-
9.60
6.60
4.30
Intangible Assets
200.00
331.40
-
-
-
-
Other Assets
-
-
-
6.40
6.40
6.40
Total Assets
785.70
349.20
6.90
57.30
27.20
226.60
ST Debt & Current Portion LT Debt
500.00
450.00
625.00
155.20
1,225.30
Accounts Payable
224.10
-
309.20
-
378.20
Other Current Liabilities
-
520.10
117.00
728.70
13,232.70
Total Current Liabilities
724.10
970.10
1,051.20
883.90
14,836.10
Total Liabilities
724.10
970.10
1,051.20
883.90
14,836.10
Common Equity (Total)
61.60
620.80
1,044.30
826.70
14,809.90
Total Shareholders' Equity
61.60
620.80
1,044.30
826.60
14,809.00
Total Equity
61.60
620.80
1,044.30
826.60
14,809.00
Liabilities & Shareholders' Equity
785.70
349.20
6.90
57.30
27.20
Preferred Stock (Carrying Value)
-
-
-
0.10
0.90
About OncBioMune Pharmaceuticals
View Profile
